234 related articles for article (PubMed ID: 26306937)
21. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
[TBL] [Abstract][Full Text] [Related]
22. Charcot-Marie-Tooth disease type 2A with an autosomal-recessive inheritance: the first report of an adult-onset disease.
Hikiami R; Yamashita H; Koita N; Jingami N; Sawamoto N; Furukawa K; Kawai H; Terashima T; Oka N; Hashiguchi A; Takashima H; Urushitani M; Takahashi R
J Hum Genet; 2018 Jan; 63(1):89-92. PubMed ID: 29215088
[TBL] [Abstract][Full Text] [Related]
23. MFN2 deletion of exons 7 and 8: founder mutation in the UK population.
Carr AS; Polke JM; Wilson J; Pelayo-Negro AL; Laura M; Nanji T; Holt J; Vaughan J; Rankin J; Sweeney MG; Blake J; Houlden H; Reilly MM
J Peripher Nerv Syst; 2015 Jun; 20(2):67-71. PubMed ID: 26114802
[TBL] [Abstract][Full Text] [Related]
24. Exome sequencing reveals mutations in MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease.
Kostera-Pruszczyk A; Kosinska J; Pollak A; Stawinski P; Walczak A; Wasilewska K; Potulska-Chromik A; Szczudlik P; Kaminska A; Ploski R
J Peripher Nerv Syst; 2014 Sep; 19(3):242-5. PubMed ID: 25403865
[TBL] [Abstract][Full Text] [Related]
25. A mutation in the heptad repeat 2 domain of MFN2 in a large CMT2A family.
Dankwa L; Richardson J; Motley WW; Züchner S; Scherer SS
J Peripher Nerv Syst; 2018 Mar; 23(1):36-39. PubMed ID: 29341354
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A.
Kijima K; Numakura C; Izumino H; Umetsu K; Nezu A; Shiiki T; Ogawa M; Ishizaki Y; Kitamura T; Shozawa Y; Hayasaka K
Hum Genet; 2005 Jan; 116(1-2):23-7. PubMed ID: 15549395
[TBL] [Abstract][Full Text] [Related]
27. Homozygous Mutations in
Asif M; Chiou CC; Hussain MF; Hussain M; Sajid Z; Gulsher M; Raheem A; Khan A; Nasreen N; Kloczkowski A; Hassan M; Iqbal F; Chen CC
DNA Cell Biol; 2023 Nov; 42(11):697-708. PubMed ID: 37797217
[TBL] [Abstract][Full Text] [Related]
28. An MFN2-related Charcot-Marie-Tooth Disease Patient with Optic Nerve Atrophy, Neurogenic Bladder Dysfunction, and Diaphragmatic Weakness.
Kimura Y; Nishikawa A; Hashiguchi A; Etoh M; Yoshimura A; Asai K; Miyashita N; Takashima H; Sumi H; Naka T
Intern Med; 2022 Jun; 61(11):1743-1747. PubMed ID: 34803088
[TBL] [Abstract][Full Text] [Related]
29. Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child.
Schon K; Spasic-Boskovic O; Brugger K; Graves TD; Abbs S; Park SM; Ambegaonkar G; Armstrong R
Neurogenetics; 2017 Jan; 18(1):49-55. PubMed ID: 28063088
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial dynamics and inherited peripheral nerve diseases.
Pareyson D; Saveri P; Sagnelli A; Piscosquito G
Neurosci Lett; 2015 Jun; 596():66-77. PubMed ID: 25847151
[TBL] [Abstract][Full Text] [Related]
31. Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation.
Di Meglio C; Bonello-Palot N; Boulay C; Milh M; Ovaert C; Levy N; Chabrol B
Brain Dev; 2016 May; 38(5):498-506. PubMed ID: 26686600
[TBL] [Abstract][Full Text] [Related]
32. A late-onset and mild form of Charcot-Marie-Tooth disease type 2 caused by a novel splice-site mutation within the Mitofusin-2 gene.
Kotruchow K; Kabzińska D; Hausmanowa-Petrusewicz I; Kochański A
Acta Myol; 2013 Dec; 32(3):166-9. PubMed ID: 24803844
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model.
Strickland AV; Rebelo AP; Zhang F; Price J; Bolon B; Silva JP; Wen R; Züchner S
J Peripher Nerv Syst; 2014 Jun; 19(2):152-64. PubMed ID: 24862862
[TBL] [Abstract][Full Text] [Related]
34. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.
Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C
Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.
Franco A; Dang X; Zhang L; Molinoff PB; Dorn GW
J Pharmacol Exp Ther; 2022 Nov; 383(2):137-148. PubMed ID: 36507849
[TBL] [Abstract][Full Text] [Related]
36. Acute optic neuropathy associated with a novel MFN2 mutation.
Leonardi L; Marcotulli C; Storti E; Tessa A; Serrao M; Parisi V; Santorelli FM; Pierelli F; Casali C
J Neurol; 2015 Jul; 262(7):1678-80. PubMed ID: 25957633
[TBL] [Abstract][Full Text] [Related]
37. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype.
Rouzier C; Bannwarth S; Chaussenot A; Chevrollier A; Verschueren A; Bonello-Palot N; Fragaki K; Cano A; Pouget J; Pellissier JF; Procaccio V; Chabrol B; Paquis-Flucklinger V
Brain; 2012 Jan; 135(Pt 1):23-34. PubMed ID: 22189565
[TBL] [Abstract][Full Text] [Related]
38. Two Spanish families with Charcot-Marie-Tooth type 2A: clinical, electrophysiological and molecular findings.
Banchs I; Casasnovas C; Montero J; Martínez-Matos JA; Volpini V
Neuromuscul Disord; 2008 Dec; 18(12):974-8. PubMed ID: 18996695
[TBL] [Abstract][Full Text] [Related]
39. Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2.
McCorquodale DS; Montenegro G; Peguero A; Carlson N; Speziani F; Price J; Taylor SW; Melanson M; Vance JM; Züchner S
J Neurol; 2011 Jul; 258(7):1234-9. PubMed ID: 21258814
[TBL] [Abstract][Full Text] [Related]
40. Mitofusin 2 gene mutation causing early-onset CMT2A with different progressive courses.
Lv H; Wang L; Li W; Qiao X; Li Y; Wang Z; Yuan Y
Clin Neuropathol; 2013; 32(1):16-23. PubMed ID: 22762946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
